期刊文献+

美国药师参与住院抗凝管理的服务模式 被引量:8

Introduce of the Pharmacist-participated Inpatient Anticoagulation Management Services in America
下载PDF
导出
摘要 在医疗保健机构的推动下,美国药师参与的住院抗凝管理服务得到快速发展,形成了系统化的服务体系,取得了很好的效果。该体系促进了药师职业发展和多学科团队建设。其优秀经验和模式值得我国药师学习和借鉴。本文从人员组成、信息系统整合、服务实施流程、服务效果评估、团队成员教育和资格认证等五部分,综述美国药师参与住院抗凝管理服务系统的模式,值得同行参考。 Under the impetus of several American healthcare institutions, pharmacist-participated inpatient anticoagulation management services have been rapidly developed, which has provided a systematic method of care that shows a great deal of promise. It promotes the professional development of pharmacists and the building of a multidisciplinary team. This model provides Chinese pharmacists a framework to improve their own system of care. This article reviews the five major aspects of the American model of pharmacist-participated inpatient anticoagulation management service in order to provide references for Chinese colleagues. The five major aspects are the multidisciplinary group, integration of information system,implementation process, effect evaluation, and member education and qualification certification.
出处 《药学与临床研究》 2015年第6期611-614,共4页 Pharmaceutical and Clinical Research
关键词 药师 抗凝管理 临床药学 Pharmacist Anticoagulation management Clinical pharmacy
  • 相关文献

参考文献4

二级参考文献23

  • 1马长生.心房颤动导管消融治疗评价[J].岭南心血管病杂志,2009,15(4):251-254. 被引量:1
  • 2The Joint Commission. National patient safety goals effective January 1, 2013. Hospital accreditation program [EB/OL]. http:// www. jointcommission, org/assets/'l/18/NPSG _ Chapter _ Jan2013 _ HAP. pdf, 2013 -03 - 14.
  • 3Kearon C, Akl EA, Comerota AJ, et al. Antithrembotic therapy for VTE disease, antithrombotic therapy and prevention of thrombosis (9th ed) :American College of Chest Physicians evidence - based clinical practice guidelines [ J]. Chest, 2012,141 ( Suppl. ) : Se44 - Se88 ,Se419 - Se494.
  • 4Wittkowsky AK, Nutescu EA, Blackburn J, et al. Outcomes of oral anticoagulant therapy managed by telephone vs in - office visits in an anticoagulation clinic setting[ J]. Chest, 2006,130 : 1385 - 1389.
  • 5Institute for Safe Medication Practices. Example of a health care fail- ure mode and effects analysis for anticoagulants [ EB/OL]. http:// www. ismp. org/Tools/FMEAofAnticoagulants, pdf, 2013 -03 -14. Institute for Safe Medication Practices. ISMP's list of high - alert medications [ EB/OL]. http ://www. ismp. org/Tools/institutionalhi- ghMert, asp, 2013 -03 - 14.
  • 6Institute for Safe Medication Practices. ISMP's list of high - alert medications [ EB/OL]. http ://www. ismp. org/Tools/institutionalhi- ghMert, asp, 2013 -03 - 14.
  • 7Stephen E,Andrea B,George L,et al.Randomized trial of lot- tery-based incentives to improve warfarin adherence[J].Am Heart J ,2012,164(2) :268-274.
  • 8胡大一.心房颤动卒中预防不可忽视患者管理[N].健康报,2014-05 -20(008).
  • 9Lip GY, Huber K, Andreotti F,et aL Management of antithrom-botic therapy in atrial fibrillation patients presenting with acutecoronary syndrome and/or undergoing percutaneous coronary in-tervention/ steting [J]. Thromb Haemost,2010,103( 1) : 13 - 28.
  • 10Camm AJ, Lip GY, De Caterina al. 2012 focused update ofthe ESC Guidelines for the management of atrial fibrillation: Anupdate of the 2010 ESC Guidelines for the management of atrialfibrillation developed with the special contribution of the Europe-an Heart Rhythm Association[J]. Europace,2012,14 (10): 1385 -1413.

共引文献37

同被引文献52

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部